Who Needs a BRCA Gene Test? New Beauty News Genetic testing for BRCA1 and BRCA2 can reveal if you have an increased risk of developing cancer, but it’s not universally recommended for everyone. Payal Shah, MD says testing should be considered for those with family history of certain cancers. Latest News F.D.A. Approves First Home Testing for 3 Breast Cancer Mutations, With Caveats New York Times News | March 2018 The FDA approved at-home genetic testing for BRCA mutations, while highlighting concerns. Susan Domchek, MD, cautioned that people may experience anxiety when undergoing genetic testing, and recommends that they discuss any concerns with their doctor. Genetic Study Makes Testing More Accessible Jewish Exponent News | March 2018 The BRCA Founder Outreach (BFOR) study, focusing on individuals of Ashkenazi descent, will give participants the opportunity to receive simpler access to genetic testing. Many Women Mistake Common Symptom of Ovarian Cancer for Indigestion Healthline News | March 2018 Healthline reports on recent research showing that many women who experience a bloating feeling on a regular basis are more likely to change their diets than visit their doctors, and in some cases, that could put women at risk of overlooking ovarian cancer symptoms. Relearning How to Date After My Double Mastectomy The Cut News | March 2018 Basser Young Leadership Council co-chair Erika Stalings reveals her experiences with dating after undergoing a preventive double mastectomy, and her struggles to decide if and when to tell dates about the surgery and her BRCA mutation status. The Role of Biomarkers in Patients with Breast Cancer Targeted Oncology News | March 2018 Susan M. Domchek, MD, Executive Director of the Basser Center, discusses the role biomarkers have in the treatment of patients with breast cancer. Identifying biomarkers in patients early on, such as knowledge of estrogen receptor status, can lead to better treatment plans, Domchek says. Think Before Trying Home Breast Cancer Gene Tests, Experts Urge USA Today News | March 2018 Genetic counselors, oncologists and other experts are urging consumers to do their homework before sending in saliva samples and allowing their DNA to be screened for certain cancer risks by the company 23andMe. When it comes to home cancer tests, think before you spit USA Today News | March 2018 U.S. consumers soon will be able to test themselves at home for some genetic mutations that increase the risk of breast, ovarian and prostate cancer — but you might want to think before you spit. Susan Domchek, MD, speaks to USA Today about BRCA mutations. BRCA Breast Cancer Patients Finally Have a Non-Chemotherapy Treatment Option Genome News | February 2018 The FDA approved the first oral treatment for breast cancer patients who have inherited mutations in their BRCA genes. Susan Domchek, MD, who was involved in the clinical trial, discusses how this is a major step forward. Faith, Fate, and Families Penn Medicine Magazine News | February 2018 Penn Medicine Magazine's latest issue includes the story of how the Basser Center was founded in memory of Faith Basser, and how BRCA mutations can impact families around the world. Breast Cancer Caused by Genetic Mutation Gets First Approved Treatment Through FDA Approval of Olaparib Philadelphia Inquirer News | January 2018 The U.S. Food and Drug Administration recently approved olaparib as the first treatment for advanced breast cancer caused by mutations in BRCA genes, in an important step in the fight against inherited cancers. Expert Discusses Promise of Olaparib/Durvalumab Combo in BRCA+ Breast Cancer Targeted Oncology News | January 2018 Susan Domchek, MD, Executive Director of the Basser Center, discussed the evolving treatment landscape for patients with BRCA-related, metastatic breast cancer. Individual Knowledge Is Power in Addressing BRCA Gene Mutations Cure Magazine News | January 2018 Last week, journalist Joan Lunden moderated a panel of experts, “Knowledge is Power: Understanding and Managing BRCA-Related Cancer Risk.” The program, co-presented by the Basser Center, focused on the latest lifesaving information surrounding BRCA-related cancers. Phil Basser Celebrates 100 Years with the Eagles Fox News News | January 2018 Basser Center co-founder Mindy Gray's family is in the news, thanks to her inspiring father, Phil Basser, whose love of the Eagles has gone viral just before his 100th birthday. Olaparib/Durvalumab Combo Effective for BRCA-mutant Breast Cancer OncLive News | December 2017 OncLive reports on recent Penn-led research showing that the combination of olaparib and durvalumab demonstrated a disease control rate of 80 percent for pretreated patients with germline BRCA-mutated, HER2- negative metastatic breast cancer. Can Telomere Length Reveal How Well You’re Aging? Good Morning America News | November 2017 TeloYears is an at-home test that promises to reveal a user's true biological age by measuring telomeres, the ends of chromosomes that wear down over time. Susan Domchek, MD, advised caution, saying there has to be more study. For Cancer Survivor, the Bell Tolls Loudly Bloomberg News | November 2017 The biennial Basser Jean Bash celebrated five years of progress toward understanding, treating and preventing hereditary cancers. The benefit honored Raquel and Michael Hass and Pulitzer Prize-winning author Siddhartha Mukherjee, MD, DPhil. Direct-to-Consumer Testing for Hereditary Cancers ‘Most Helpful’ when Integrated with Established Health Care Practice Healio News | October 2017 Basser's Angela Bradbury, MD, says one of the biggest challenges is that many patients don't have access to genetic counselors. A Pill Might Control Pancreatic Cancer, Even If It Doesn't Cure It Forbes News | September 2017 Forbes takes a deep dive into the use of PARP inhibitors in the fight against pancreatic cancer, which features a recently opened trial led by Kim A. Reiss Binder, MD, an assistant professor of Hematology Oncology. Pagination First page« First Previous page‹‹ … Page7 Page8 Page9 Page10 Page11 Page12 Page13 Current page14 Page15 Next page›› Last pageLast »
Who Needs a BRCA Gene Test? New Beauty News Genetic testing for BRCA1 and BRCA2 can reveal if you have an increased risk of developing cancer, but it’s not universally recommended for everyone. Payal Shah, MD says testing should be considered for those with family history of certain cancers.
F.D.A. Approves First Home Testing for 3 Breast Cancer Mutations, With Caveats New York Times News | March 2018 The FDA approved at-home genetic testing for BRCA mutations, while highlighting concerns. Susan Domchek, MD, cautioned that people may experience anxiety when undergoing genetic testing, and recommends that they discuss any concerns with their doctor.
Genetic Study Makes Testing More Accessible Jewish Exponent News | March 2018 The BRCA Founder Outreach (BFOR) study, focusing on individuals of Ashkenazi descent, will give participants the opportunity to receive simpler access to genetic testing.
Many Women Mistake Common Symptom of Ovarian Cancer for Indigestion Healthline News | March 2018 Healthline reports on recent research showing that many women who experience a bloating feeling on a regular basis are more likely to change their diets than visit their doctors, and in some cases, that could put women at risk of overlooking ovarian cancer symptoms.
Relearning How to Date After My Double Mastectomy The Cut News | March 2018 Basser Young Leadership Council co-chair Erika Stalings reveals her experiences with dating after undergoing a preventive double mastectomy, and her struggles to decide if and when to tell dates about the surgery and her BRCA mutation status.
The Role of Biomarkers in Patients with Breast Cancer Targeted Oncology News | March 2018 Susan M. Domchek, MD, Executive Director of the Basser Center, discusses the role biomarkers have in the treatment of patients with breast cancer. Identifying biomarkers in patients early on, such as knowledge of estrogen receptor status, can lead to better treatment plans, Domchek says.
Think Before Trying Home Breast Cancer Gene Tests, Experts Urge USA Today News | March 2018 Genetic counselors, oncologists and other experts are urging consumers to do their homework before sending in saliva samples and allowing their DNA to be screened for certain cancer risks by the company 23andMe.
When it comes to home cancer tests, think before you spit USA Today News | March 2018 U.S. consumers soon will be able to test themselves at home for some genetic mutations that increase the risk of breast, ovarian and prostate cancer — but you might want to think before you spit. Susan Domchek, MD, speaks to USA Today about BRCA mutations.
BRCA Breast Cancer Patients Finally Have a Non-Chemotherapy Treatment Option Genome News | February 2018 The FDA approved the first oral treatment for breast cancer patients who have inherited mutations in their BRCA genes. Susan Domchek, MD, who was involved in the clinical trial, discusses how this is a major step forward.
Faith, Fate, and Families Penn Medicine Magazine News | February 2018 Penn Medicine Magazine's latest issue includes the story of how the Basser Center was founded in memory of Faith Basser, and how BRCA mutations can impact families around the world.
Breast Cancer Caused by Genetic Mutation Gets First Approved Treatment Through FDA Approval of Olaparib Philadelphia Inquirer News | January 2018 The U.S. Food and Drug Administration recently approved olaparib as the first treatment for advanced breast cancer caused by mutations in BRCA genes, in an important step in the fight against inherited cancers.
Expert Discusses Promise of Olaparib/Durvalumab Combo in BRCA+ Breast Cancer Targeted Oncology News | January 2018 Susan Domchek, MD, Executive Director of the Basser Center, discussed the evolving treatment landscape for patients with BRCA-related, metastatic breast cancer.
Individual Knowledge Is Power in Addressing BRCA Gene Mutations Cure Magazine News | January 2018 Last week, journalist Joan Lunden moderated a panel of experts, “Knowledge is Power: Understanding and Managing BRCA-Related Cancer Risk.” The program, co-presented by the Basser Center, focused on the latest lifesaving information surrounding BRCA-related cancers.
Phil Basser Celebrates 100 Years with the Eagles Fox News News | January 2018 Basser Center co-founder Mindy Gray's family is in the news, thanks to her inspiring father, Phil Basser, whose love of the Eagles has gone viral just before his 100th birthday.
Olaparib/Durvalumab Combo Effective for BRCA-mutant Breast Cancer OncLive News | December 2017 OncLive reports on recent Penn-led research showing that the combination of olaparib and durvalumab demonstrated a disease control rate of 80 percent for pretreated patients with germline BRCA-mutated, HER2- negative metastatic breast cancer.
Can Telomere Length Reveal How Well You’re Aging? Good Morning America News | November 2017 TeloYears is an at-home test that promises to reveal a user's true biological age by measuring telomeres, the ends of chromosomes that wear down over time. Susan Domchek, MD, advised caution, saying there has to be more study.
For Cancer Survivor, the Bell Tolls Loudly Bloomberg News | November 2017 The biennial Basser Jean Bash celebrated five years of progress toward understanding, treating and preventing hereditary cancers. The benefit honored Raquel and Michael Hass and Pulitzer Prize-winning author Siddhartha Mukherjee, MD, DPhil.
Direct-to-Consumer Testing for Hereditary Cancers ‘Most Helpful’ when Integrated with Established Health Care Practice Healio News | October 2017 Basser's Angela Bradbury, MD, says one of the biggest challenges is that many patients don't have access to genetic counselors.
A Pill Might Control Pancreatic Cancer, Even If It Doesn't Cure It Forbes News | September 2017 Forbes takes a deep dive into the use of PARP inhibitors in the fight against pancreatic cancer, which features a recently opened trial led by Kim A. Reiss Binder, MD, an assistant professor of Hematology Oncology.
